Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Feb;38(1):74-81.
doi: 10.1002/hon.2696. Epub 2019 Dec 6.

Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia

Alexander D Heini  1 , Rebecca Hugo  1 , Martin D Berger  1 , Urban Novak  1 , Ulrike Bacher  2   3 , Thomas Pabst  1
Affiliations
Free article
Clinical Trial

Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia

Alexander D Heini et al. Hematol Oncol. 2020 Feb.
Free article

Abstract

High levels of acute phase reactants can be associated with adverse outcome in patients with various solid tumor types. For patients with acute myeloid leukemia (AML), this correlation is unknown. We retrospectively investigated the prognostic value of pretreatment acute phase protein levels in 282 consecutive newly diagnosed AML patients undergoing at least one cycle of intensive induction chemotherapy. We applied a new score integrating pre-treatment C-reactive protein (CRP), fibrinogen, and albumin levels termed the CFA ratio, and we stratified patients into two groups: Patients with a CFA ratio below 3.06 had decisively better progression-free (26.2 vs 7.7 months; P < .001), disease-free (56.4 vs 8.7 months; P < .001), and overall survival (61.2 vs 13.8 months; P < .001). Results remained significant when adjusting for confounders including European Leukemia Network risk group. Early mortality also tended to be lower in the low CFA ratio group. Finally, patients with lower modified Glasgow prognostic score (mGPS) similarly had better outcome. In conclusion, our data suggest that an elevated CFA ratio as well as a high mGPS are associated with adverse outcome in patients with newly diagnosed AML undergoing intensive induction. These parameters should undergo prospective evaluation for their contribution to risk profiling in AML patients.

Keywords: C-reactive protein; acute myeloid leukemia; acute phase protein; albumin; fibrinogen; prognosis, outcome.

PubMed Disclaimer

References

REFERENCES

    1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867. https://doi.org/10.1038/nature01322.
    1. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park). 2002;16(2):217-226.
    1. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med. 1990;7(2):147-159.
    1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-454. https://doi.org/10.1056/NEJM199902113400607.
    1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-1812.

Publication types

MeSH terms